WASHINGTON, May 13 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Estar Technologies Ltd. from its Center for Biologics Evaluation and Research:

* * *

Recipient: Aaron Esteron, Chief Executive Officer and Founder, Estar Technologies Ltd, 15, Ha-Merkava, Holon 5885111, Israel, Aaron@estar-medical.com

Issuing Office: Center for Biologics Evaluation and Research, United States